In addition, drug-tolerant persister cells are highly dependent on GPx4 for survival, and loss of GPx4 function contributes to ferroptotic cell death and prevents drug resistance, suggesting a novel therapeutic avenue in cancers [12]. This evidence concerns the gene GPX4 and cancer.